This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Imcheck Therapeutics Sas, Institut Jean Paoli & Irène Calmettes. Active years: 2025.
Company Filing History:
1 out of 5,383 
1 out of 4 
1 out of 32 
Years Active: 2025
Title: Innovations by Carla Cano in Cancer Treatment
Introduction
Carla Cano is an accomplished inventor based in Marseilles, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of antibodies.
Latest Patents
Carla Cano holds a patent for "Antibodies having specificity for BTN2 and uses thereof." This invention relates to antibodies that specifically target BTN2A, with potential applications in cancer treatment. Her work in this area demonstrates her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Carla has worked with notable organizations, including Imcheck Therapeutics SAS and the Institut National de la Santé et de la Recherche Médicale. These experiences have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Carla has collaborated with esteemed colleagues such as Etienne Foucher and Kieu Suong Le. Their combined expertise has further enhanced the impact of her work in the medical research community.
Conclusion
Carla Cano's innovative contributions to cancer treatment through her patented antibodies highlight her dedication to improving healthcare. Her work continues to inspire advancements in medical research and treatment options for patients.